Date: April 25, 2021 Source: Syracuse University Summary: In an experimental pain study of CBD in humans, researchers conclude that CBD pain relief is driven by both pharmacological action and psychological placebo effects. It’s been hailed as a wonder drug and it’s certainly creating wonder profits. By some estimates, the Cannabidiol (or CBD) market could […]
Cannabis and Cannabinoid Research James M. Nichols and Barbara L.F. Kaplan Published Online:4 Sep 2019 https://doi.org/10.1089/can.2018.0073 Abstract Introduction: Cannabidiol (CBD) as Epidiolex® (GW Pharmaceuticals) was recently approved by the U.S. Food and Drug Administration (FDA) to treat rare forms of epilepsy in patients 2 years of age and older. Together with the increased societal acceptance […]
Cannabis and Cannabinoid Research Vol. 2, No. 1 Kerstin Iffland and Franjo Grotenhermen Published Online:1 Jun 2017 https://doi.org/10.1089/can.2016.0034 Abstract Introduction: This literature survey aims to extend the comprehensive survey performed by Bergamaschi et al. in 2011 on cannabidiol (CBD) safety and side effects. Apart from updating the literature, this article focuses on clinical studies and CBD […]
Pain. 2017 Dec; 158(12): 2442–2451. Published online 2017 Sep 1. doi: [10.1097/j.pain.0000000000001052] Holly T. Philpott Abstract Osteoarthritis (OA) is a multifactorial joint disease, which includes joint degeneration, intermittent inflammation, and peripheral neuropathy. Cannabidiol (CBD) is a noneuphoria producing constituent of cannabis that has the potential to relieve pain. The aim of this study was to […]